Chronic Myeloid Leukemia: Understanding Loss of Response
0 Views
administrator
07/08/23
Harry P. Erba, MD; Jorge E. Cortes, MD; and Michael Mauro, MD, provide their perspective on loss of response and mechanisms of resistance as they pertain to switching therapy with BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia.
-
Category
Show more
Facebook Comments
No comments found